Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group
ClinicalTrials.gov Identifier:
NCT00899899
First received: May 9, 2009
Last updated: September 28, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2006
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)